Scale -


  • Ebitda is -3.42 Rs Cr; Annual Growth is 76 %; in Bottom Quartile
  • PBT is -2.48 Rs Cr; Annual Growth is 37 %; in Bottom Quartile
  • PAT is -16.93 Rs Cr; Annual Growth is 37 %; in Bottom Quartile
  • Revenue is 23.73 Rs Cr; Annual Decline is -45 %; Continuous Decline over 3 years; in Bottom Quartile; 5 Year CAGR is -21 %
  • Quarterly Revenue is 6.98 Rs Cr; in Bottom Quartile

Profitability -


  • PBDIT Margin is -14.42 %; Annual Growth is 56 %; in Bottom Quartile
  • PAT Margin is -71.35 %; Annual Decline is -15 %; Continuous Decline over 3 years; in Bottom Quartile
  • Quarterly Profit margin is -36 %; in Bottom Quartile

Return -


  • ROCE is -19.62 %; Annual Growth is 39 %; in Bottom Quartile
  • ROA is -10.37 %; Annual Growth is 35 %; in Bottom Quartile
  • Asset Turnover is 14 %; Annual Decline is -44 %; Continuous Decline over 3 years; in Bottom Quartile; 5 Year CAGR is -20 %
  • ROE is 0 %; in Bottom Quartile

Efficiency -


  • Operating cash flow is -1.92 Rs Cr; Annual Growth is 76 %; in Bottom Quartile
  • Current Ratio is 0.09; Continuous Decline over 3 years; in Bottom Quartile; 5 Year CAGR is -33 %
  • Quick Ratio is 0.03; Continuous Decline over 3 years; in Bottom Quartile; 5 Year CAGR is -31 %

Solvancy -


  • Debt/Equity is -1.38; Annual Decline is -146 %; Continuous Decline over 3 years; in Bottom Quartile
  • Contingent Liabilities is 0 Rs Cr; Annual Decline is -100 %; in Bottom Quartile
  • Long term Debt is 164 Rs Cr; Annual Growth is 423 %; in Top Quartile; 5 Year CAGR is 173 %
  • Total Debt is 225 Rs Cr; Annual Growth is 173 %; Continuous Growth over 3 years; 5 Year CAGR is 104 %

Quality -


  • Change in Inventories/Total Expenses is 1 %; Annual Decline is -81 %; in Top Quartile
  • Operating cashflow/ebitda is 56 %; Continuous Growth over 3 years
  • Other Expenses/Total Expenses is 43 %; Continuous Decline over 3 years; in Top Quartile; 5 Year CAGR is 76 %
  • Current Tax/PAT is 0 %; in Bottom Quartile
  • Operating cashflow/PAT is 11 %; Annual Decline is -61 %; 5 Year CAGR is -26 %
  • Exceptional Items/PBT is 0 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem


Sector
Major Subsidiaries/Associates
Key Clients

Products


Products
Product details

Operations


Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
Krebs Biochemicals KREBSBIO H1 FY27 Financial Results
Krebs Biochemicals Posts Q2 Loss of Rs 5.4 Cr; Ipca Merger Awaits
Krebs Biochemicals Q2FY27 Results: Net loss widens 117% QoQ to ?540 lakh
Krebs Biochemicals & Industries (KREBSBIO) Share Price Fall Streak: Second Straight Session of Decline
Krebs Biochemicals KREBSBIO Q2 FY27 Regulation 74(5) Filing
Krebs Biochemicals and Industries vs Nifty 50: Returns Compared
Krebs Biochemicals Ltd (NSE: KREBSBIO) Gains 10.80% as Stock Draws Market Attention
Krebs Biochemicals Share Price News: Price Action Review